Back to mobile site

Cytosorbents (CTSO) Misses Q1 EPS by 7c

May 4, 2021 4:25 PM EDT

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.10), $0.07 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $11.5 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings